News

There’s more to blue cheese than just the stench

Max Esterhuizen
By Max Esterhuizen
July 21, 2024

Marbled veins of blue line the otherwise antique white surface.

As you approach, the pungent smell fills your nostrils, akin to gym socks for some.

But there’s far more to blue cheese than just the stink. The marbled veins of blue, which are edible Penicilliummolds, produce compounds with antifungal, antibacterial, and other biological properties in high doses also known as natural products.

Sydney Johnson (at left) and Pablo Sobrado found a way to synthesize on a large scale a naturally occurring compound that hasn’t previously been used for antibacterial applications.
Max Esterhuizen for Virginia Tech
Sydney Johnson (at left) and Pablo Sobrado found a way to synthesize on a large scale a naturally occurring compound that hasn’t previously been used for antibacterial applications.

Virginia Tech researchers found a new, efficient way to synthesize some of these beneficial blue cheese compounds in a way that avoids the use of harmful chemicals. Previously, the synthesization of these compounds was either extremely low in yield or required the use of harmful or dangerous chemicals.

“This discovery explains the mechanism behind a new reaction in our field, filling a knowledge gap,” said Sydney Johnson Ph.D. ’24, the lead author who earned her doctorate in biochemistry.

Antibacterial resistance has become a growing problem for society, which was caused by the overuse of natural products used on the market for decades, Johnson said.

By finding a way to synthesize on a large scale a naturally occurring compound that hasn’t previously been used for antibacterial applications, Virginia Tech researchers were able to evade the existing antibacterial resistances.

“We work with an enzyme that can help create a natural product that has a unique structure that would make it very difficult for pathogens to become resistant,” Johnson said. “Existing pathogens would have to evolve to be resistant to this new compound.”

The paper was recently published in ACS Biochemistry.

This publication lays the foundation to utilize the enzyme to synthesize the natural products,” Sydney Johnson said.
Max Esterhuizen for Virginia Tech
"This publication lays the foundation to utilize the enzyme to synthesize the natural products,” Sydney Johnson said.

“I like to train innovative scientists that work on trying to move the science forward by developing projects that move the entire field forward,” said Pablo Sobrado, professor of biochemistry who leads the Sobrado Lab and is also a researcher on the paper. “Sydney achieved that with this research.”

Enzymes are proteins that help speed up chemical reactions. For their experiment, researchers used an enzyme that produces something called roquefortine L. Parts of its chemical structure are biologically active, which means that it can have beneficial properties such as antimicrobial activities.

In addition, the production of roquefortine L is central to the production of other molecules called glandiclone, melegranin, and oxaline, which have been shown to have broad antimicrobial properties and promising anticancer effects against human breast and leukemia cancer cells.

This enzyme attaches two hydroxyl groups to a nitrogen atom, which are functional groups found in sugars and alcohols. A hydroxyl group consists of one hydrogen and one oxygen atom. Through a complex chemical process, the hydroxyl groups then develop an entirely different functionality.

“This has not been studied in detail before, and Sydney showed how the enzyme holds on first to the product that has the one hydroxyl group, attaches the second group, and then obtains the final product,” Sobrado said.

Many fungal species make this compound naturally, and it’s relatively new in the biochemistry field to research how to synthesize these processes at a large scale. According to the researchers, the reaction mechanism and the actual chemistry that takes place on the involved nitrogen atom is completely novel from other publications.

“This publication lays the foundation to utilize the enzyme to synthesize the natural products,” Johnson said. “The improvements make this process much more marketable. Eventually, we could get a drug containing one of these compounds or something similar to it to the market.”

This article is republished from the Virginia Tech News page. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Max Esterhuizen
Max Esterhuizen

Max Esterhuizen is a communications and marketing specialist who has spent his career in higher education and in sports journalism. As the assistant director for communications and marketing for the College of Agriculture and Life Sciences at Virginia Tech, Max tells and shares stories inside the college, AREC, and Virginia Cooperative Extension. He also helps lead the Office of Communications and Marketing in a digital-first strategy that aligns with the college’s advancement priorities and helps promote the research and academics of the college as well as the impact of Virginia Cooperative Extension and Virginia Agricultural Experiment Station. While in the college, Max has served as the editor of the college’s flagship publication, which has won national awards and landed media placements in outlets ranging from NPR’s Science Friday to Rolling Stone.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

Animals have used bioluminescence to communicate for millions of years
News

Animals have used bioluminescence to communicate for millions of years

July 13, 2024

Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.

Getting to the genetic basis of cardiovascular disease
Journal News

Getting to the genetic basis of cardiovascular disease

July 11, 2024

Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.